About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Infectious Disorders - Drug Targets
›
Top Articles
Infectious Disorders - Drug Targets
Pharmacology
,
Biology
,
Microbiology
1.1
(top 14%)
Impact Factor
1.2
(top 14%)
extended IF
47
(top 9%)
H-Index
624
authors
745
papers
8.4K
citations
2.1K
citing journals
8.9K
citing authors
Most Cited Articles of Infectious Disorders - Drug Targets
Title
Year
Citations
Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease
2006
181
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
2011
149
Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy
2010
146
Overview of the diagnosis of cytomegalovirus infection
2011
121
Potential roles of histones in host defense as antimicrobial agents
2008
121
Mycobacterium tuberculosis DNA gyrase as a target for drug discovery
2007
104
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants
2009
100
Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins
2006
99
Drug targets in mycobacterial sulfur metabolism
2007
91
The role of antimicrobial peptides in human skin and in skin infectious diseases
2008
85
Nucleoside analog inhibitors of hepatitis C virus replication
2006
83
Targeting the formation of the cell wall core of M. tuberculosis
2007
83
Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants
2009
81
The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control
2007
81
Respiratory syncytial virus infection in adult populations
2012
80
Toll-like receptors in skin infections and inflammatory diseases
2008
80
The Seattle Structural Genomics Center for Infectious Disease (SSGCID)
2009
77
Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein
2012
75
Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives
2010
71
The burgeoning burden of respiratory syncytial virus among children
2012
70
Virus vasculopathy and stroke: an under-recognized cause and treatment target
2010
69
Drug targets in cytomegalovirus infection
2009
69
Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms
2008
67
Tetraspanins: gateways for infection
2012
59
Targeting bacterial secretion systems: benefits of disarmament in the microcosm
2007
58
previous
2006
2007
2008
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.